Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 13;22(9):1533.
doi: 10.3390/molecules22091533.

Optimization and Comparison of Synthetic Procedures for a Group of Triazinyl-Substituted Benzene-Sulfonamide Conjugates with Amino Acids

Affiliations

Optimization and Comparison of Synthetic Procedures for a Group of Triazinyl-Substituted Benzene-Sulfonamide Conjugates with Amino Acids

Dominika Krajčiová et al. Molecules. .

Abstract

Sulfonamides incorporating 1,3,5-triazine moieties can selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII, and XIV over cytosolic isoforms I and II. In the present work, a highly effective synthetic procedure was proposed for this group of potent cancerostatic drugs and compared with previously used methods. The synthesis of triazinyl-substituted benzene-sulfonamide conjugates with amino acids can be easily carried out using sodium carbonate-based water solution as a synthetic medium instead of N,N-Diisopropylethylamine/Dimethylformamide. The benefits of this synthetic procedure include: (i) high selectivity of the creation of disubstituted conjugates; (ii) several times higher yield (≥95%) than that achieved previously; (iii) elimination of organic solvents by the use of an environmental friendly water medium (green chemistry); (iv) simple and fast isolation of the product. The synthesis and resulting products were evaluated using TLC, IR, NMR, and MS methods. The present work demonstrates a significant advantage in providing shortened routes to target structures.

Keywords: 1,3,5-triazine conjugates; amino acids; carboanhydrase inhibitors; sulfonamides; synthesis optimization.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any conflict of interest concerning the present work.

Figures

Scheme 1
Scheme 1
Synthesis of 4-(4′,6′-dichloro-1′,3′,5′-triazin-2′-ylamino)-benzene-sulfonamide precursor 1. Reagents and conditions: 4-aminobenzenesulfanilamide, cyanuric chloride, acetone, at 0 °C, was added to an aqueous solution of NaOH, stirred for 1 h, and the reaction was subsequently quenched by the addition of slush (100 mL), after which the solid was filtered off. The scheme is reprinted from [4], with permission of the publisher. Product yield: 95%.
Scheme 2
Scheme 2
Synthesis of dimethyl 2′′,2′′′-[6′-(4-sulfamoylphenylamino)-1′,3′,5′-triazine-2′,4′-diyl]-bis(azanediyl)diacetate intermediate 2. Reagents and conditions: a mixture of methyl 2-aminoacetate hydrochloride, DMF, and DIPEA was stirred for 2 h at r.t. Then, 4-(4′,6′-dichloro-1′,3′,5′-triazin-2′-ylamino)-benzene-sulfonamide 1 dissolved DMF was added, and the mixture was stirred at 90 °C under an argon atmosphere overnight. Product yield: 37%.
Scheme 3
Scheme 3
Hydrolysis of 2′′,2′′′-[6′-(4-sulfamoylphenylamino)-1′,3′,5′-triazine-2′,4′-diyl]-bis(azanediyl)diacetate intermediate 2 to product 3. Reagents and conditions: a mixture of 2′′,2′′′-[6′-(4-sulfamoylphenylamino)-1′,3′,5′-triazine-2′,4′-diyl]-bis(azanediyl)diacetate 2, MeOH, LiOH, and H2O was stirred at r.t. for 3 h. Product yield: 64%.
Scheme 4
Scheme 4
Synthesis of 2′′,2′′′-[6′-(4-sulfamoylphenylamino)-1′,3′,5′-triazine-2′,4′-diyl]-bis(azanediyl)diacetic acid 3. Reagents and conditions: 4-(4′,6′-dichloro-1′,3′,5′-triazin-2′-ylamino)-benzene-sulfonamide 1, glycine, NaOH, and H2O were refluxed for 24 h. Product yield: 65%.
Scheme 5
Scheme 5
Synthesis of 2′′,2′′′-[6′-(4-sulfamoylphenylamino)-1′,3′,5′-triazine-2′,4′-diyl]-bis(azanediyl)diacetic acid 3. Reagents and conditions: 4-(4′,6′-dichloro-1′,3′,5′-triazin-2′-ylamino)-benzene-sulfonamide 1, glycine, Na2CO3, and H2O were refluxed for 24 h. Product yield: 96%.
Scheme 6
Scheme 6
Synthesis of 3′′,3′′′-[6′-(4-sulfamoylphenylamino)-1′,3′,5′-triazine-2′,4′-diyl]-bis(azanediyl)dipropanoic acid 4. Reagents and conditions: 4-(4′,6′-dichloro-1′,3′,5′-triazin-2′-ylamino)-benzene-sulfonamide 1, β-alanine, Na2CO3, and H2O were refluxed for 24 h. Product yield: 95%.

References

    1. Cecchi A., Winum J.Y., Innocenti A., Vullo D., Montero J.L., Scozzafava A., Supuran C.T. Carbonic anhydrase inhibitors: Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes І, ІІ, and ІX with sulfonamides derived from 4-isothiocyanato-benzolamide. Bioorg. Med. Chem. Lett. 2004;14:5775–5780. doi: 10.1016/j.bmcl.2004.09.062. - DOI - PubMed
    1. Sharma B.K., Pilania P., Singh P., Sharma S., Prabhakar Y.S. CP-MLR directed QSAR study of carbonic anhydrase inhibitors as sulfonamide and sulfamate inhibitors. Cent. Eur. J. Chem. 2009;7:909–922. doi: 10.2478/s11532-009-0073-4. - DOI
    1. Vullo D., Franchi M., Gallori E., Pastorek J., Scozzafava A., Pastorekova S., Supuran C.T. Carbonic anhydrase inhibitors: Inhibition of tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. 2003;13:1005–1009. doi: 10.1016/S0960-894X(03)00091-X. - DOI - PubMed
    1. Carta F., Garaj V., Maresca A., Wagner J., Avvaru B.S., Robbins A.H., Scozzafava A., McKenna R., Supuran C.T. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Bioorg. Med. Chem. 2011;19:3105–3119. doi: 10.1016/j.bmc.2011.04.005. - DOI - PubMed
    1. Ceruso M., Vullo D., Scozzafava A., Supuran C.T. Inhibition of human carbonic anhydrase isoforms I–XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties. Bioorg. Med. Chem. 2013;21:6929–6936. doi: 10.1016/j.bmc.2013.09.031. - DOI - PubMed

LinkOut - more resources